LEADER
Phase 1/2 Completed
30 enrolled 9 charts
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
Phase 2 Completed
57 enrolled 14 charts
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
Phase 1 Completed
32 enrolled
DiTuSarc
Phase 2 Completed
7 enrolled
ANNOUNCE
Phase 3 Completed
509 enrolled 23 charts
Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes
Phase 2 Completed
57 enrolled 18 charts
A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients
Phase 1 Completed
56 enrolled
Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma
Phase 2 Completed
20 enrolled 11 charts
A Study of Nivolumab in Selected Uterine Cancer Patients
Phase 2 Completed
35 enrolled 8 charts
ALCI2
Phase 1 Completed
10 enrolled
ImmunoSarc
Phase 1/2 Completed
197 enrolled
A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)
Phase 1 Completed
41 enrolled
Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
Phase 2 Completed
73 enrolled 11 charts
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Phase 2 Completed
17 enrolled
M6620 (VX-970) in Selected Solid Tumors
Phase 2 Completed
30 enrolled 15 charts
STRASS
Phase NA Completed
266 enrolled 19 charts
PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
Phase NA Completed
70 enrolled
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Phase 3 Completed
588 enrolled 22 charts
SAMHY SARCOME
Phase NA Completed
60 enrolled
TRAVELL
Phase 2 Completed
105 enrolled
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
Phase 2 Completed
54 enrolled 12 charts
VORTEX
Phase 3 Completed
216 enrolled
ALCI
Phase 1 Completed
74 enrolled 25 charts
MALTED
Phase 1 Completed
37 enrolled
LMS03
Phase 2 Completed
106 enrolled
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Phase 1/2 Completed
24 enrolled 14 charts
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Phase 1/2 Completed
78 enrolled 11 charts
A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma
Phase 2 Completed
113 enrolled 13 charts
A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Phase 3 Completed
16 enrolled
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
Phase 2 Completed
17 enrolled 9 charts
TAUL
Phase 2 Completed
168 enrolled
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase 2 Completed
72 enrolled 13 charts
Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
Phase 2 Completed
40 enrolled 11 charts
Bevacizumab and Radiation Therapy for Sarcomas
Phase 2 Completed
20 enrolled 16 charts
Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma
Phase 2 Completed
27 enrolled 4 charts
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
Phase 1 Completed
3 enrolled
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Phase 2 Completed
185 enrolled
Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
Phase 2 Completed
90 enrolled
A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma
Phase 3 Completed
579 enrolled 13 charts
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
Phase 3 Completed
370 enrolled
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Phase 1 Completed
30 enrolled
Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma
Phase 2 Completed
148 enrolled 8 charts
Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
Phase 2 Completed
47 enrolled 7 charts
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Phase 2 Completed
53 enrolled 6 charts
Sorafenib and Dacarbazine in Soft Tissue Sarcoma
Phase 2 Completed
37 enrolled 6 charts
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
121 enrolled
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)
Phase 2 Completed
216 enrolled
Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas
Phase 1 Completed
5 enrolled
Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Phase 2 Completed
47 enrolled 16 charts